Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1

被引:114
作者
Chauchereau, A [1 ]
Amazit, L [1 ]
Quesne, M [1 ]
Guiochon-Mantel, A [1 ]
Milgrom, E [1 ]
机构
[1] Hop Bicetre, INSERM, U 135, F-94275 Le Kremlin Bicetre, France
关键词
D O I
10.1074/jbc.M207148200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
SUMO-1 (small ubiquitin-like modifier) conjugation regulates the subcellular localization, stability, and activity of a variety of proteins. We show here that SUMO-1 overexpression markedly enhances progesterone receptor (PR)-mediated gene transcription. PR undergoes a sumoylation at lysine 388 located in its N-terminal domain. However, sumoylation of the receptor is not responsible for enhanced transcription because substitution of its target lysine did not abolish the effect of SUMO-1 and even converted the receptor into a slightly more active transactivator. Furthermore estrogen receptor alpha (ERalpha)-driven transcription is also enhanced by SUMO-1 overexpression contrasting with the absence of sumoylation of this receptor. We thus analyzed SUMO-1 conjugation to the steroid receptor coactivator SRC-1. We showed that this protein contains two major sites of conjugation at Lys-732 and Lys-774. Sumoylation was shown to increase PR-SRC-1 interaction and to prolong SRC-1 retention in the nucleus. It did not prevent SRC-1 ubiquitinylation and did not exert a clear effect on the stability of the protein. Overexpression of SUMO-1 enhanced PR-mediated gene transcription even in the presence of non-sumoylated mutants of SRC-1. This observation suggests that among the many protein partners involved in steroid hormone-mediated gene regulation several are probably targets of SUMO-1 modification.
引用
收藏
页码:12335 / 12343
页数:9
相关论文
共 75 条
[1]   The inhibitory function in human progesterone receptor N termini binds SUMO-1 protein to regulate autoinhibition and transrepression [J].
Abdel-Hafiz, H ;
Takimoto, GS ;
Tung, L ;
Horwitz, KB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (37) :33950-33956
[2]  
Boddy MN, 1996, ONCOGENE, V13, P971
[3]  
Boudjelal M, 2000, CANCER RES, V60, P2247
[4]   CRYSTAL-STRUCTURE OF THE LIGAND-BINDING DOMAIN OF THE HUMAN NUCLEAR RECEPTOR RXR-ALPHA [J].
BOURGUET, W ;
RUFF, M ;
CHAMBON, P ;
GRONEMEYER, H ;
MORAS, D .
NATURE, 1995, 375 (6530) :377-382
[5]   Ligands specify coactivator nuclear receptor (NR) box affinity for estrogen receptor subtypes [J].
Bramlett, KS ;
Wu, YF ;
Burris, TP .
MOLECULAR ENDOCRINOLOGY, 2001, 15 (06) :909-922
[6]   Molecular basis of agonism and antagonism in the oestrogen receptor [J].
Brzozowski, AM ;
Pike, ACW ;
Dauter, Z ;
Hubbard, RE ;
Bonn, T ;
Engstrom, O ;
Ohman, L ;
Greene, GL ;
Gustafsson, JA ;
Carlquist, M .
NATURE, 1997, 389 (6652) :753-758
[7]   RETRACTED: SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53 (Retracted Article) [J].
Buschmann, T ;
Fuchs, SY ;
Lee, CG ;
Pan, ZQ ;
Ronai, Z .
CELL, 2000, 101 (07) :753-762
[8]   Posttranslational modification of TEL and TEL/AML1 by SUMO-1 and cell-cycle-dependent assembly into nuclear bodies [J].
Chakrabarti, SR ;
Sood, R ;
Nandi, S ;
Nucifora, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (24) :13281-13285
[9]  
CHAUCHEREAU A, 1991, J BIOL CHEM, V266, P18280
[10]   JAB1 interacts with both the progesterone receptor and SRC-1 [J].
Chauchereau, A ;
Georgiakaki, M ;
Perrin-Wolff, M ;
Milgrom, E ;
Loosfelt, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :8540-8548